
In 2 pivotal phase 3 studies, all 5 readers hit sensitivity and specificity targets for florquinitau F 18 tau PET, including in patients with early symptomatic Alzheimer disease.
MAD Arts features works by artists recovering from mental illness in special exhibition in partnership with National Art Exhibitions of the Mentally Ill.



